A new trading day began on Monday, with FibroGen Inc (NASDAQ: FGEN) stock price down -3.79% from the previous day of tradingbefore settling in for the closing price of $0.47. FGEN’s price has ranged from $0.33 to $2.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -2.51%. Meanwhile, its annual earnings per share averaged 65.07%. With a float of $93.37 million, this company’s outstanding shares have now reached $98.77 million.
Considering the fact that the conglomerate employs 486 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 76.65%, operating margin of -91.86%, and the pretax margin is -98.64%.
FibroGen Inc (FGEN) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of FibroGen Inc is 7.00%, while institutional ownership is 56.39%. The most recent insider transaction that took place on Jun 12 ’24, was worth 25,884. In this transaction Chief Medical Officer of this company bought 22,123 shares at a rate of $1.17, taking the stock ownership to the 82,123 shares. Before that another transaction happened on Mar 07 ’24, when Company’s CEO bought 50,000 for $1.91, making the entire transaction worth $95,470. This insider now owns 470,178 shares in total.
FibroGen Inc (FGEN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 65.07% per share during the next fiscal year.
FibroGen Inc (NASDAQ: FGEN) Trading Performance Indicators
Here are FibroGen Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.71, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of FibroGen Inc (FGEN)
Compared to the last year’s volume of 2.47 million, its volume of 1.02 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 88.10%. Additionally, its Average True Range was 0.05.
During the past 100 days, FibroGen Inc’s (FGEN) raw stochastic average was set at 8.67%, which indicates a significant decrease from 78.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 115.84% in the past 14 days, which was lower than the 144.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6337, while its 200-day Moving Average is $1.1615. Nevertheless, the first resistance level for the watch stands at $0.4749 in the near term. At $0.4977, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5101. If the price goes on to break the first support level at $0.4397, it is likely to go to the next support level at $0.4273. Now, if the price goes above the second support level, the third support stands at $0.4045.
FibroGen Inc (NASDAQ: FGEN) Key Stats
With a market capitalization of 45.40 million, the company has a total of 99,474K Shares Outstanding. Currently, annual sales are 147,750 K while annual income is -284,230 K. The company’s previous quarter sales were 50,640 K while its latest quarter income was -15,540 K.
